ATE308337T1 - Hgf zur behandlung von akutem nierenversagen - Google Patents

Hgf zur behandlung von akutem nierenversagen

Info

Publication number
ATE308337T1
ATE308337T1 AT98907233T AT98907233T ATE308337T1 AT E308337 T1 ATE308337 T1 AT E308337T1 AT 98907233 T AT98907233 T AT 98907233T AT 98907233 T AT98907233 T AT 98907233T AT E308337 T1 ATE308337 T1 AT E308337T1
Authority
AT
Austria
Prior art keywords
hgf
treatment
kidney failure
acute kidney
administering
Prior art date
Application number
AT98907233T
Other languages
English (en)
Inventor
Ikue Mori
Konohana-Ku Chome
Tomokazu Nagano
Original Assignee
Nakamura Toshikazu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nakamura Toshikazu filed Critical Nakamura Toshikazu
Application granted granted Critical
Publication of ATE308337T1 publication Critical patent/ATE308337T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
AT98907233T 1997-03-15 1998-03-12 Hgf zur behandlung von akutem nierenversagen ATE308337T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8223597 1997-03-15
PCT/JP1998/001081 WO1998041227A1 (en) 1997-03-15 1998-03-12 Hgf for treating acute renal failure

Publications (1)

Publication Number Publication Date
ATE308337T1 true ATE308337T1 (de) 2005-11-15

Family

ID=13768753

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907233T ATE308337T1 (de) 1997-03-15 1998-03-12 Hgf zur behandlung von akutem nierenversagen

Country Status (8)

Country Link
US (1) US6436388B2 (de)
EP (1) EP0979097B1 (de)
JP (2) JP4865936B2 (de)
AT (1) ATE308337T1 (de)
AU (1) AU6311498A (de)
DE (1) DE69832165T2 (de)
TW (1) TW527190B (de)
WO (1) WO1998041227A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE372127T1 (de) * 1997-12-03 2007-09-15 Nakamura Toshikazu Präparation zur kontinuierlichen intravenösen verabreichung
WO2000007615A1 (fr) * 1998-08-05 2000-02-17 Sumitomo Pharmacueticals Co., Ltd. Preparations destinees a l'administration d'un facteur de croissance des hepatocytes
ATE481111T1 (de) * 2000-01-31 2010-10-15 Rothenpieler Uwe Waldemar Pax2 zur behandlung von nierenkrankheiten
US7612046B2 (en) 2000-01-31 2009-11-03 Uwe Waldemar Rothenpieler Method for treating kidney disorders
US8048806B2 (en) 2000-03-17 2011-11-01 Applied Materials, Inc. Methods to avoid unstable plasma states during a process transition
US8617351B2 (en) 2002-07-09 2013-12-31 Applied Materials, Inc. Plasma reactor with minimal D.C. coils for cusp, solenoid and mirror fields for plasma uniformity and device damage reduction
AU2001284576A1 (en) 2000-08-28 2002-03-13 Fariba Nayeri The synergetic effects of hgf and antibacterial treatment
TWI283899B (en) * 2002-07-09 2007-07-11 Applied Materials Inc Capacitively coupled plasma reactor with magnetic plasma control
US7125835B2 (en) * 2002-10-10 2006-10-24 International Flavors & Fragrances Inc Encapsulated fragrance chemicals
US7658913B2 (en) 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091180A (en) * 1987-11-20 1992-02-25 Administrators Of The Tulane Educational Fund Protection against rhabdomyolysis-induced nephrotoxicity
JPH03255096A (ja) 1990-03-01 1991-11-13 Toyobo Co Ltd 組換ラット肝実質細胞増殖因子
JP2777678B2 (ja) 1990-06-11 1998-07-23 敏一 中村 組換ヒト肝実質細胞増殖因子及びその製造方法
JP2750372B2 (ja) 1990-06-19 1998-05-13 敏一 中村 賢疾患治療剤
US5360790A (en) * 1990-12-11 1994-11-01 The Regents Of The University Of Michigan Method and formulations for the therapy of acute renal failure
WO1994006456A1 (en) * 1992-09-16 1994-03-31 Genentech, Inc. Protection against liver damage by hgf
AU7254896A (en) * 1995-10-05 1997-04-28 Genentech Inc. Improved angiogenesis using hepatocyte growth factor
JP3255096B2 (ja) 1997-10-01 2002-02-12 株式会社ニコン 露光装置及び露光方法

Also Published As

Publication number Publication date
JP4865936B2 (ja) 2012-02-01
AU6311498A (en) 1998-10-12
EP0979097A1 (de) 2000-02-16
US20010047079A1 (en) 2001-11-29
DE69832165T2 (de) 2006-04-20
DE69832165D1 (de) 2005-12-08
JP2001516358A (ja) 2001-09-25
EP0979097B1 (de) 2005-11-02
JP2010100664A (ja) 2010-05-06
TW527190B (en) 2003-04-11
US6436388B2 (en) 2002-08-20
WO1998041227A1 (en) 1998-09-24

Similar Documents

Publication Publication Date Title
DE69616333T2 (de) Thip zur behandlung von schlafstörungen
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
DE69634900D1 (de) Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
ATE308337T1 (de) Hgf zur behandlung von akutem nierenversagen
EA199900124A2 (ru) Способ лечения сердечной недостаточности
DE69943107D1 (de) Behandlung von autoimmunerkrankungen
DE69313872D1 (de) Verbindung von nucleocidanaloga zur behandlung viraler infektionen
ATE210455T1 (de) Vwf propeptide enthaltendes pharmazeutisches präparat
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE69607559D1 (de) Verfahren zur Behandlung von Phenolteer
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
ATE293972T1 (de) Behandlung von chronischen schmerzen
DE69736180D1 (de) Behandlung von manischen erkrankungen
ATE203162T1 (de) Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4- aza-5 alpha-androst-1-en-3-one
ATE149840T1 (de) Behandlung von leberkrebs
DE69623767T2 (de) Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus
DE69917445D1 (de) Reinigung von carboxaldehyd
ATE167398T1 (de) Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide
DE60024408D1 (de) Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen
ATE486594T1 (de) Methode zur behandlung von herzinsuffizienz
ATE74004T1 (de) Mischung zur behandlung von hypercholesterolemie.
DE69927591D1 (de) Behandlung von nierenkolik mit gaba-analogen
DE69108588D1 (de) Behandlung von Wolle.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties